Eversept Partners, LP Mckesson Corp Transaction History

Eversept Partners, LP

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$300.57 - $336.42 $15.7 Million - $17.6 Million	-52,375 Closed	0 $0
Q1 2022 Nov 08, 2023	BUY	$244.61 - $310.48 $12.8 Million - $16.3 Million	52,375 New	52,375 $16 Million
Q1 2022 May 16, 2022	SELL	$244.61 - $310.48 $20.5 Million - $26 Million	-83,736 Reduced 61.52%	52,375 $16.1 Million
Q4 2021 Nov 08, 2023	SELL	$198.21 - $248.9 $5.07 Million - $6.37 Million	-25,597 Reduced 15.83%	136,111 $33.8 Million
Q4 2021 Feb 14, 2022	SELL	$198.21 - $248.9 $5.07 Million - $6.37 Million	-25,597 Reduced 15.83%	136,111 $33.9 Million
Q3 2021 Nov 08, 2023	BUY	$188.42 - $208.66 $16.3 Million - $18.1 Million	86,708 Added 115.61%	161,708 $32.2 Million
Q3 2021 Nov 15, 2021	BUY	$188.42 - $208.66 $16.3 Million - $18.1 Million	86,708 Added 115.61%	161,708 $32.3 Million
Q2 2021 Nov 08, 2023	SELL	$184.89 - $202.68 $8.87 Million - $9.73 Million	-47,983 Reduced 39.02%	75,000 $14.3 Million
Q2 2021 Aug 16, 2021	SELL	$184.89 - $202.68 $8.87 Million - $9.73 Million	-47,983 Reduced 39.02%	75,000 $14.4 Million
Q1 2021 Nov 08, 2023	BUY	$169.52 - $196.53 $20.8 Million - $24.2 Million	122,983 New	122,983 $24 Million
Q1 2021 May 13, 2021	BUY	$169.52 - $196.53 $20.8 Million - $24.2 Million	122,983 New	122,983 $24 Million

1,713

112M

871K

900K

Ticker MCK
Exchange NYSE
Sector Healthcare
Industry Medical Distribution
Shares Outstandng 143,730,000
Market Cap $75.6B
Description
McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, International, Medical-Surgical Solutions, and Prescription Technology Solutions (RxTS). The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar, and over-the-counter phar...

Get notified when there are updates to the investment portfolio of Eversept Partners, LP, based on Form 13F filings with the SEC.

Stay updated on Eversept Partners, LP with notifications on news.